The store will not work correctly when cookies are disabled.
2-(4-Fluorophenyl)-N-{N'-[2-(4-fluorophenyl)acetyl]-hydrazinocarbothioyl}acetamide
ID: ALA4102906
PubChem CID: 89717853
Max Phase: Preclinical
Molecular Formula: C17H15F2N3O2S
Molecular Weight: 363.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Cc1ccc(F)cc1)NNC(=S)NC(=O)Cc1ccc(F)cc1
Standard InChI: InChI=1S/C17H15F2N3O2S/c18-13-5-1-11(2-6-13)9-15(23)20-17(25)22-21-16(24)10-12-3-7-14(19)8-4-12/h1-8H,9-10H2,(H,21,24)(H2,20,22,23,25)
Standard InChI Key: FLJGDLMAXZINCU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
13.4473 -12.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7382 -12.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4473 -13.3081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1564 -12.0823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2795 -12.4909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5704 -12.0823 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9845 -12.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6936 -12.4909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9845 -11.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6936 -10.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6936 -10.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4027 -9.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1118 -10.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1118 -10.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4027 -11.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8167 -9.6307 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.8655 -12.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8655 -13.3081 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.7382 -11.2651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0332 -10.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0332 -10.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7382 -9.6307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4473 -10.0393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4473 -10.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7382 -8.8135 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
7 8 2 0
7 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
13 16 1 0
9 10 1 0
5 7 1 0
17 18 2 0
6 17 1 0
4 17 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
22 25 1 0
2 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.39 | Molecular Weight (Monoisotopic): 363.0853 | AlogP: 1.77 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.23 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.54 | CX Basic pKa: ┄ | CX LogP: 2.88 | CX LogD: 2.88 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.57 | Np Likeness Score: -1.65 |
References
1. Mori H, Wada R, Takahara S, Horino Y, Izumi H, Ishimoto T, Yoshida T, Mizuguchi M, Obita T, Gouda H, Hirono S, Toyooka N.. (2017) A novel serine racemase inhibitor suppresses neuronal over-activation in vivo., 25 (14): [PMID:28533113] [10.1016/j.bmc.2017.05.011] |
2. (2014) Serine racemase inhibitor, |